Practice points - Neonatal Intensive Care Drug Manual

|
Neonatal Intensive Care Drug Manual
|
bet | 138/654 | Sana | 03.01.2022 | Hajmi | 1,5 Mb. | | #14803 |
Practice points
|
|
References
|
1. Thomson Reuters, Neofax 2011, Poractant Alfa Monograph, page 308-309.
2. Hey E. Neonatal Formulary 6, 2011, Surfactants, page 248–249.
3. MIMS, Curosurf Product Information, 2010, Ascent Pharma.
4. Sweet et al. European Consensus Guidelines on the Management of Neonatal Respiratory Distress Syndrome in Preterm Infants – 2013 Update, Neonatology 2013;103:353–368.
5. Soll R, Özek E. Prophylactic animal derived surfactant extract for preventing morbidity and mortality in preterm infants. Cochrane Database of Systematic Reviews 1997, Issue 4. Art. No.: CD000511. DOI: 10.1002/14651858.CD000511.
6. Bahadue FL, Soll R. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. Cochrane Database of Systematic Reviews 2012, Issue 11. Art. No.: CD001456. DOI: 10.1002/14651858.CD001456.pub2.
7. Singh N, Hawley KL, Viswanathan K: Efficacy of porcine versus bovine surfactants for preterm newborns with respiratory distress syndrome: systematic review and meta-analysis. Pediatrics 2011; 128:e1588–e1595.
8. Rojas-Reyes MX, Morley CJ, Soll R: Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants. Cochrane Database of Systematic Reviews 2012:CD000510.
9. Soll R, Ozek E: Multiple versus single doses of exogenous surfactant for the prevention or treatment of neonatal respiratory distress syndrome. Cochrane Database of Systematic Reviews 2009:CD000141.
10. Corbet A et al. Double-blind randomized trial of one versus three prophylactic doses of synthetic surfactant in 826 neonates weighing 700 to 1000 grams: effects on mortality rate. Journal of Pediatrics 1995;126:969–78.
11. Dunn MS, Shennan AT, Possmayer F. Single- vs multiple-dose surfactant replacement therapy in neonates of 30 to 36 weeks’ gestation with respiratory distress syndrome. Pediatrics 1990;86:564–71.
12. Speer CP et al: Randomized European multicenter trial of surfactant replacement therapy for severe neonatal respiratory distress syndrome: single versus multiple doses of Curosurf. Pediatrics 1992; 89: 13–20.
13. Halliday HL et al. (1993) Multicentre randomised trial comparing high and low dose surfactant regimens for the treatment of respiratory distress syndrome (the Curosurf 4 trial), Archives of Disease in Childhood; 69: 276–280
14. Figueras-Aloy J et al. Early administration of the second dose of surfactant (beractant) in the treatment of severe hyaline membrane disease. Acta Paediatr 2001;90:296–301.
15. El Shahed AI, Dargaville PA, Ohlsson A, Soll R, Surfactant for meconium aspiration syndrome in full term/near term infants (Review), Cochrane Database of Systematic Reviews 2007, Issue 3. Art. No. CD002054.
16. Findlay RD et al. Surfactant Replacement Therapy for Meconium Aspiration Syndrome, Pediatrics 1996, 97(1):48–52.
17. Lotze et al. Multicenter study of surfactant (beractant) use in the treatment of term infants with severe respiratory failure, The Journal of Pediatrics 1998, 132(1):40–47
18. Chinese Collaborative Study Group for Neonatal Respiratory Diseases, Treatment of severe meconium aspiration syndrome with porcine surfactant: A multicentre, randomized, controlled trial, Acta Pædiatrica, 2005; 94: 896–902.
19. Hahn S, Choi HJ, Soll R, Dargaville PA, Lung lavage for meconium aspiration syndrome in newborn infants (Review), Cochrane Database of Systematic Reviews 2013, Issue 4. Art. No.: CD003486.
|
Original version Date: 27/10/2015
|
Author: NeoMed Consensus Group
|
Current Version number: 2
|
Current Version Date: 10-12-2020
|
Risk Rating: Low
|
Due for Review: 10-12-2025
|
Approved by: DTC
|
Approval Date: TBA
|
|
| |